Tumoren und Pseudotumoren der Netzhaut und des Ziliarepithels

Die Varietät retinaler Tumoren reicht von harmlosen Läsionen über benigne, lokal destruierende Tumoren bis hin zu lebensbedrohlichen Erkrankungen. Nicht immer lassen sie sich einfach voneinander unterscheiden. Die Diagnose sollte nach Möglichkeit klinisch gestellt werden wegen der Gefahr einer Tumorzellverschleppung durch invasive Diagnostik. Jedoch rückt die genetische Charakterisierung der Läsion immer mehr in den Vordergrund. Je nach Entität ist eine Therapie in einem spezialisierten Zentrum notwendig.

Publication History

Article published online:
30 April 2021

• Literatur

• 1 Dimaras H, Corson TW, Cobrinik D. et al Retinoblastoma. Nat Rev Dis Primers 2015; 1: 15021 DOI: 10.1038/nrdp.2015.21.
• 2 Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 2005; 18: 41-53, viii DOI: 10.1016/j.ohc.2004.11.003.
• 3 Lohmann D. Retinoblastoma. Adv Exp Med Biol 2010; 685: 220-227 DOI: 10.1007/978-1-4419-6448-9_21.
• 4 Biewald E, Holdt M, Bornfeld N. Neue Therapiestrategien beim Retinoblastom: Nichtsystemische Chemotherapie. Ophthalmologe 2014; 111: 379-382 DOI: 10.1007/s00347-014-3038-8.
• 5 Temming P, Arendt M, Viehmann A. et al Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center. Pediatr Blood Cancer 2017; 64: 71-80 DOI: 10.1002/pbc.26193.
• 6 Bechrakis NE, Bornfeld N, Schueler A. et al Clinicopathologic features of retinoblastoma after primary chemoreduction. Arch Ophthalmol 1998; 116: 887-893 DOI: 10.1001/archopht. 116.7.887.
• 7 Shields CL, Mashayekhi A, Au AK. et al The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006; 113: 2276-2280 DOI: 10.1016/j.ophtha. 2006.06.018.
• 8 Pekacka A. The Role of Intraarterial Chemotherapy in the Management of Retinoblastoma. J Ophthalmol 2020; 2020: 3638410 DOI: 10.1155/2020/3638410.
• 9 Manjandavida FP, Stathopoulos C, Zhang J. et al Intra-arterial chemotherapy in retinoblastoma – A paradigm change. Indian J Ophthalmol 2019; 67: 740-754 DOI: 10.4103/ijo.IJO_866_19.
• 10 Biewald EM, Bornfeld N, Metz KA. et al Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy. Br J Ophthalmol 2019; DOI: 10.1136/bjophthalmol-2019-315209.
• 11 Suzuki S, Aihara Y, Fujiwara M. et al Intravitreal injection of melphalan for intraocular retinoblastoma. Jpn J Ophthalmol 2015; 59: 164-172 DOI: 10.1007/s10384-015-0378-0.
• 12 Munier FL, Gaillard MC, Balmer A. et al Intravitreal chemotherapy for vitreous seeding in retinoblastoma: Recent advances and perspectives. Saudi J Ophthalmol 2013; 27: 147-150 DOI: 10.1016/j.sjopt.2013.06.003.
• 13 Francis JH, Brodie SE, Marr B. et al Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience. Ophthalmology 2017; 124: 488-495 DOI: 10.1016/j. ophtha.2016.12.015.
• 14 Sen M, Shields CL, Honavar SG. et al Coats disease: An overview of classification, management and outcomes. Indian J Ophthalmol 2019; 67: 763-771 DOI: 10.4103/ijo.IJO_841_19.
• 15 Robitaille JM, Zheng B, Wallace K. et al The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease. Br J Ophthalmol 2011; 95: 574-579 DOI: 10.1136/bjo.2010.190116.
• 16 Statland JM, Sacconi S, Farmakidis C. et al Coats syndrome in facioscapulohumeral dystrophy type 1: frequency and D4Z4 contraction size. Neurology 2013; 80: 1247-1250 DOI: 10.1212/WNL.0b013e3182897116.
• 17 Daruich AL, Moulin AP, Tran HV. et al Subfoveal nodule in coatsʼ disease: Toward an updated classification predicting visual prognosis. Retina 2017; 37: 1591-1598 DOI: 10.1097/IAE.0000000000001399.
• 18 Kase S, Rao NA, Yoshikawa H. et al Expression of vascular endothelial growth factor in eyes with Coatsʼ disease. Invest Ophthalmol Vis Sci 2013; 54: 57-62 DOI: 10.1167/iovs.12-10613.
• 19 Kusaka S. Surgical management of coats disease. Asia Pac J Ophthalmol (Phila) 2018; 7: 156-159 DOI: 10.22608/APO.201867.
• 20 Kaliki S, Taneja S, Palkonda VAR. Inadvertent intraocular surgery in children with unsuspected retinoblastoma: a study of 14 cases. Retina 2019; 39: 1794-1801 DOI: 10.1097/IAE.0000000000002214.
• 21 Soliman SE, Wan MJ, Heon E. et al Retinoblastoma versus advanced Coatsʼ disease: Is enucleation the answer?. Ophthalmic Genet 2017; 38: 291-293 DOI: 10.1080/13816810.2016.1199715.
• 22 Hiscott P, Mudhar H. Is vasoproliferative tumour (reactive retinal glioangiosis) part of the spectrum of proliferative vitreoretinopathy?. Eye 2009; 23: 1851-1858 DOI: 10.1038/eye.2008.351.
• 23 Anastassiou G, Bornfeld N, Schueler AO. et al Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina. Br J Ophthalmol 2006; 90: 447-450 DOI: 10.1136/bjo.2005.081422.
• 24 Hussain RN, Jmor F, Damato B. et al Verteporfin photodynamic therapy for the treatment of retinal vasoproliferative tumors. Ophthalmology 2015; 122: 2361-2363 DOI: 10.1016/j.ophtha. 2015.05.026.
• 25 Saito W, Kase S, Fujiya A. et al Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors. Retina 2013; 33: 1959-1967 DOI: 10.1097/IAE.0b013e3182923490.
• 26 Smith J, Steel D. The surgical management of vasoproliferative tumours. Ophthalmologica 2011; 226 (Suppl. 01) 42-45 DOI: 10.1159/000328209.
• 27 Binderup MLM, Stendell AS, Galanakis M. et al Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease. Br J Ophthalmol 2018; 102: 942-947 DOI: 10.1136/bjophthalmol-2017-310884.
• 28 Latif F, Tory K, Gnarra J. et al Identification ofnthe von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260: 1317-1320 DOI: 10.1126/science.8493574.
• 29 Richards FM, Payne SJ, Zbar B. et al Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet 1995; 4: 2139-2143 DOI: 10.1093/hmg/4.11.2139.
• 30 Schmid S, Gillessen S, Binet I. et al Management of von Hippel-Lindau disease: an interdisciplinary review. Oncol Res Treat 2014; 37: 761-771 DOI: 10.1159/000369362.
• 31 Singh AD, Nouri M, Shields CL. et al Treatment of retinal capillary hemangioma. Ophthalmology 2002; 109: 1799-1806 DOI: 10.1016/s0161-6420(02)01177-6.
• 32 Gaudric A, Krivosic V, Duguid G. et al Vitreoretinal surgery for severe retinal capillary hemangiomas in von hippel-lindau disease. Ophthalmology 2011; 118: 142-149 DOI: 10.1016/j. ophtha.2010.04.031.
• 33 Bornfeld N, Kreusel KM. Kapilläre Hämangiome der Netzhaut beim Von-Hippel-Lindau-Syndrom. Neue Therapieansätze. Ophthalmologe 2007; 104: 114-118 DOI: 10.1007/s00347-007-1485-1.
• 34 Kreusel KM, Bornfeld N, Lommatzsch A. et al Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology 1998; 105: 1386-1392 DOI: 10.1016/S0161-6420(98)98017-4.
• 35 Garcia-Arumi J, Sararols LH, Cavero L. et al Therapeutic options for capillary papillary hemangiomas. Ophthalmology 2000; 107: 48-54 DOI: 10.1016/s0161-6420(99)00018-4.
• 36 Hussain RN, Jmor F, Damato B. et al Verteporfin photodynamic therapy for the treatment of sporadic retinal capillary haemangioblastoma. Photodiagnosis Photodyn Ther 2015; 12: 555-560 DOI: 10.1016/j.pdpdt.2015.10.008.
• 37 Magee MA, Kroll AJ, Lou PL. et al Retinal capillary hemangiomas and von Hippel-Lindau disease. Semin Ophthalmol 2006; 21: 143-150 DOI: 10.1080/08820530500350712.
• 38 Heimann H, Damato B. Congenital vascular malformations of the retina and choroid. Eye 2010; 24: 459-467 DOI: 10.1038/eye.2009.310.
• 39 Hewick S, Lois N, Olson JA. Circumferential peripheral retinal cavernous hemangioma. Arch Ophthalmol 2004; 122: 1557-1560 DOI: 10.1001/archopht.122.10.1557.
• 40 Holdt M, Jurklies C, Schueler A. et al Intraokulare Medulloepitheliome – klinische Serie mit 10 Fällen. Klin Monatsbl Augenheilkd 2009; 226: 1017-1022 DOI: 10.1055/s-0028-1109944.
• 41 Zimmerman LE. Verhoeffʼs “terato-neuroma”. A critical reappraisal in light of new observations and current concepts of embryonic tumors. The Fourth Frederick H. Verhoeff Lecture. Am J Ophthalmol 1971; 72: 1039-1057
• 42 Tadepalli SH, Shields CL, Shields JA. et al Intraocular medulloepithelioma – A review of clinical features, DICER 1 mutation, and management. Indian J Ophthalmol 2019; 67: 755-762 DOI: 10.4103/ijo.IJO_845_19.
• 43 Shields JA, Shields CL. Glial tumors of the retina. The 2009 King Khaled Memorial Lecture. Saudi J Ophthalmol 2009; 23: 197-201 DOI: 10.1016/j.sjopt.2009.10.003.
• 44 Rowley SA, OʼCallaghan FJ, Osborne JP. Ophthalmic manifestations of tuberous sclerosis: a population based study. Br J Ophthalmol 2001; 85: 420-423 DOI: 10.1136/bjo.85.4.420.
• 45 Toteberg-Harms M, Sturm V, Sel S. et al Retinal astrocytomas: long-term follow-up. Klin Monatsbl Augenheilkd 2011; 228: 337-339 DOI: 10.1055/s-0031-1273228.
• 46 Good WV, Erodsky MC, Edwards MS. et al Bilateral retinal hamartomas in neurofibromatosis type 2. Br J Ophthalmol 1991; 75: 190 DOI: 10.1136/bjo.75.3.190.
• 47 Cohen VM, Shields CL, Furuta M. et al Vitreous seeding from retinal astrocytoma in three cases. Retina 2008; 28: 884-888 DOI: 10.1097/IAE.0b013e3181669781.
• 48 Shields JA, Eagle jr RC, Shields CL. et al Aggressive retinal astrocytomas in 4 patients with tuberous sclerosis complex. Arch Ophthalmol 2005; 123: 856-863 DOI: 10.1001/archopht. 123.6.856.
• 49 Bornfeld N, Messmer EP, Theodossiadis G. et al Giant cell astrocytoma of the retina. Clinicopathologic report of a case not associated with Bournevilleʼs disease. Retina 1987; 7: 183-189
• 50 Singh AD, Soto H, Bellerive C. et al Reactive retinal astrocytic tumor (focal nodular gliosis): report of the clinical spectrum of 3 cases. Ocul Oncol Pathol 2017; 3: 235-239 DOI: 10.1159/000455151.
• 51 Shields JA, Bianciotto CG, Kivela T. et al Presumed solitary circumscribed retinal astrocytic proliferation: the 2010 Jonathan W. Wirtschafter Lecture. Arch Ophthalmol 2011; 129: 1189-1194 DOI: 10.1001/archophthalmol.2011.211.
• 52 Shields CL, Materin MA, Marr BP. et al Resolution of exudative retinal detachment from retinal astrocytoma following photodynamic therapy. Arch Ophthalmol 2008; 126: 273-274 DOI: 10.1001/archophthalmol.2007.54.
• 53 Ramasubramanian A, Shields CL, Kytasty C. et al Resection of intraocular tumors (partial lamellar sclerouvectomy) in the pediatric age group. Ophthalmology 2012; 119: 2507-2513 DOI: 10.1016/j.ophtha.2012.06.044.
• 54 Marciano S, Mutolo MG, Siracusano M. et al Everolimus for retinal astrocytic hamartomas in tuberous sclerosis complex. Ophthalmol Retina 2018; 2: 257-260 DOI: 10.1016/j. oret.2017.08.005.
• 55 Gass JD. An unusual hamartoma of the pigment epithelium and retina simulating choroidal melanoma and retinoblastoma. Trans Am Ophthalmol Soc 1973; 71: 171-183 ; discussions 184–185
• 56 Dedania VS, Ozgonul C, Zacks DN. et al Novel classification system for combined hamartoma of the retina and retinal pigment epithelium. Retina 2018; 38: 12-19 DOI: 10.1097/IAE.0000000000001499.
• 57 Grant EA, Trzupek KM, Reiss J. et al Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2. Ophthalmic Genet 2008; 29: 133-138 DOI: 10.1080/13816810802206507.
• 58 Cohn AD, Quiram PA, Drenser KA. et al Surgical outcomes of epiretinal membranes associated with combined hamartoma of the retina and retinal pigment epithelium. Retina 2009; 29: 825-830 DOI: 10.1097/IAE.0b013e31819b1788.
• 59 Regillo CD, Eagle Jr RC, Shields JA. et al Histopathologic findings in congenital grouped pigmentation of the retina. Ophthalmology 1993; 100: 400-405 DOI: 10.1016/s0161-6420 (93)31635-0.
• 60 Shields CL, Materin MA, Walker C. et al Photoreceptor loss overlying congenital hypertrophy of the retinal pigment epithelium by optical coherence tomography. Ophthalmology 2006; 113: 661-665 DOI: 10.1016/j.ophtha.2005.10.057.
• 61 Rehan S, Aye K. In patients with a positive family history of familial adenomatous polyposis can the condition be diagnosed from the presence of congenital hypertrophy of the retinal pigment epithelium detected via an eye examination: A systematic review. Clin Exp Ophthalmol 2020; 48: 98-116 DOI: 10.1111/ceo.13643.
• 62 Trichopoulos N, Augsburger JJ, Schneider S. Adenocarcinoma arising fromcongenital hypertrophy of the retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 2006; 244: 125-128 DOI: 10.1007/s00417-005-0011-x.